Skip to main content

Advertisement

Table 1 Patients characteristics (n = 6)

From: Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study

Characteristic Number patients (%)
Age (years)  
     40-49 1 (16.7)
     50-59 4 (66.7)
     60-69 1 (16.7)
Race  
     African-American 1(16.7)
     Caucasian 5 (83.3)
GOG Performance Status  
     0 5 (83.3)
     1 0 (0.0)
     2 1 (16.7)
Ovarian cancer sub-type  
     Endometrioid 1 (16.7)
     Mixed epithelial carcinoma 1 (16.7)
     Serous adenocarcinoma 4 (66.7)
Prior therapy  
     Chemotherapy 6 (100)
          Median number prior regimens (range) 1(1)
     Surgery 6 (100)
  1. GOG = Gynecologic Oncology Group.